Carregando...
Nesfatin-1 Levels Predict Angiographic No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction
BACKGROUND: Nesfatin-1 is a novel peptide possessing pleiotropic metabolic effects. No-reflow phenomenon (NR) is a poor prognostic indicator occurring in around 30% of all patients undergoing primary percutaneous coronary interventions (pPCI). Inflammation and complexity of coronary artery disease (...
Na minha lista:
| Publicado no: | Acta Cardiol Sin |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taiwan Society of Cardiology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355118/ https://ncbi.nlm.nih.gov/pubmed/32675923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.202007_36(4).20200207A |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|